Halozyme Therapeutics
(NASDAQ:HALO)
$40.37
-0.49[-1.20%]
At close: Mar 18
$40.37
0[0.00%]
After Hours: 4:00PM EDT

GET A REPORT ON HALO SENT RIGHT TO YOUR INBOX

62.5%
Overview Rating
Good
Technicals Analysis
100
0100
Financials Analysis
40
0100

Halozyme Therapeutics Stock (NASDAQ:HALO), Quotes and News Summary

Halozyme Therapeutics Stock (NASDAQ: HALO) stock price, news, charts, stock research, profile.
Open$40.930
Close$40.370
Volume / Avg.1.046M / 1.410M
Day Range40.320 - 40.960
52 Wk Range29.850 - 45.000
Market Cap$5.120B
P/E Ratio19.471
Dividend Yield-
ExchangeNASDAQ
RSI
57
Short Interest
7.19%
Days to Cover7.38

Recent News

40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Ratings
Oct 23
3
Dec 23
1
Jan
3
1
Feb
2
Strong Buy
Buy
Hold
Sell
Strong Sell
About Halozyme Therapeutics Inc.
Sector
Health Care
Industry
Biotechnology
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
HALO
IMVT

FAQ

Q

How do I buy Halozyme Therapeutics (HALO) stock?

A

You can purchase shares of Halozyme Therapeutics (NASDAQ: HALO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Halozyme Therapeutics's (HALO) competitors?

Q

What is the target price for Halozyme Therapeutics (HALO) stock?

A

The latest price target for Halozyme Therapeutics (NASDAQ: HALO) was reported by TD Cowen on Thursday, February 29, 2024. The analyst firm set a price target for 54.00 expecting HALO to rise to within 12 months (a possible 33.76% upside). 22 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Halozyme Therapeutics (HALO)?

A

The stock price for Halozyme Therapeutics (NASDAQ: HALO) is $40.37 last updated March 18, 2024 at 4:00 PM EDT.

Q

Does Halozyme Therapeutics (HALO) pay a dividend?

A

There are no upcoming dividends for Halozyme Therapeutics.

Q

When is Halozyme Therapeutics (NASDAQ:HALO) reporting earnings?

A

Halozyme Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Q

Is Halozyme Therapeutics (HALO) going to split?

A

There is no upcoming split for Halozyme Therapeutics.

Q

What sector and industry does Halozyme Therapeutics (HALO) operate in?

A

Halozyme Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch